Achieve Life Sciences (NASDAQ: ACHV) awards stock options and RSUs to director
Rhea-AI Filing Summary
Achieve Life Sciences director Christopher Nathan received equity compensation on July 27, 2026, consisting of stock options for 25,000 shares with a $6.18 exercise price expiring July 27, 2036, and 16,700 RSUs. Both awards vest 100% on the earlier of July 27, 2027 or immediately before the 2027 annual meeting, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Martin Christopher Nathan
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 25,000 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit (RSU) F2, F3 | 16,700 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 25,000 shares (Direct);
Restricted Stock Unit (RSU) — 16,700 shares (Direct)
Footnotes (3)
- F1. The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
- F2. Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement.
- F3. Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
Key Figures
Stock options granted: 25,000 shares
Option exercise price: $6.18 per share
Option expiration: July 27, 2036
+2 more
5 metrics
Stock options granted
25,000 shares
Stock Option grant to director on July 27, 2026
Option exercise price
$6.18 per share
Exercise price for 25,000 stock options
Option expiration
July 27, 2036
Expiration date of granted stock options
RSUs granted
16,700 units
Restricted Stock Unit grant on July 27, 2026
Full vesting trigger date
July 27, 2027
Earlier of this date or just before 2027 annual meeting for 100% vesting
Key Terms
Stock Option (right to buy), Restricted Stock Unit (RSU), contingent right, vesting
4 terms
Stock Option (right to buy) financial
"Security titled Stock Option (right to buy) with $6.18 exercise price"
Restricted Stock Unit (RSU) financial
"Security titled Restricted Stock Unit (RSU) representing common stock"
A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.
contingent right financial
"Each RSU represents a contingent right to receive one share"
vesting financial
"The options vest 100% on the earlier of July 27, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did ACHV director Christopher Nathan receive on July 27, 2026?
He received 25,000 stock options and 16,700 restricted stock units (RSUs) tied to Achieve Life Sciences common stock. These awards represent additional equity-based compensation granted to him as a director on that date.
What are the key terms of the stock options granted to ACHV director Christopher Nathan?
The stock options cover 25,000 shares at an exercise price of $6.18 per share, expiring on July 27, 2036. They vest 100% on the earlier of July 27, 2027 or immediately before the 2027 annual stockholders’ meeting, subject to continued service.
How do the RSUs granted to ACHV director Christopher Nathan vest?
The 16,700 RSUs vest 100% on the earlier of July 27, 2027 or the date immediately prior to Achieve Life Sciences’ 2027 annual meeting. Vesting requires that he continue providing service to the company through the applicable vesting date.
What does each RSU granted to ACHV director Christopher Nathan represent?
Each RSU represents a contingent right to receive one share of Achieve Life Sciences common stock upon settlement. Actual share delivery occurs only after the vesting conditions are met and settlement takes place under the award terms.
Were ACHV director Christopher Nathan’s July 27, 2026 awards made under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is marked as not applicable (unchecked), and the footnotes describe standard vesting terms. It identifies these transactions as equity grants rather than trades executed under a pre-arranged 10b5-1 trading plan.